Skip to main content
. Author manuscript; available in PMC: 2010 Mar 25.
Published in final edited form as: Respir Physiol Neurobiol. 2008 Nov 18;165(2-3):167–174. doi: 10.1016/j.resp.2008.11.006

Figure 3. Dose dependent changes in PGI2 production in HMVEC-L.

Figure 3

HMVEC-L were treated with tryptase (2, 20, 200 ng/ml) or thrombin (0.1, 0.5, 1.0 IU/ml ) for upto 60 min. and PGI2 production was measured. Values represent mean ± SE for 4 separate experiments. ** P< 0.01 when compared to control cells.